Immunofluorescence results in ovarian cancer cells showed that HIF1α was more prominently localized in the nucleus of resistant cells (Fig. 6A), and knocking down the expression of CRABP2 significantly reduced the level of nuclear HIF1α (Fig. 6B). Here, CRABP2 is linked to ovarian cancer.